Brahms’ Second Symphony, Under the Direction of Rafael Payare

Maison symphonique September 26, 2021

This event has ended

See upcoming Classical events

Rafael Payare conducts the OSM in a program including two works by masters of the Germanic repertoire for large ensemble. Haydn set the standard for the Classical symphony and his contribution to the concerto genre was indispensable. Both achievements merge in his Sinfonia Concertante, which in this performance showcases four OSM soloists. Brahms pursued Haydn’s symphonic legacy, developing its distinctive 19th-century discourse. His Symphony no. 2 combines gentleness, dance, and drama, culminating in a triumphant finale.  

This concert also features Louise Farrenc’s Overture No. 2, an articulate blend of clarity and dynamism, with a buoyantly energetic theme. Farrenc was a Piano Professor at the Paris Conservatoire, solidly ranking among the finest pianists and composers in France of her time.

Louise Farrenc
Ouverture no. 2 in E-flat major, op. 24

Symphonia Concertante in B-flat major, Hob.I:105

Symphony no. 2 in D major, op. 73


Masks must be worn at all times

Vaccine passport required
Masks must be worn at all times

Vaccine passport required

Please note that physical distancing protocols are in effect for this performance, which means that 1 seat will remain empty on each side of seated spectators, except for spectators from the same family bubble.

To attend the performance, ticketholders must comply with the usual health and safety measures, in addition to meeting the following two criteria:

  • All spectators aged 13 and up must show a vaccine passport, along with a proof of ID, at the entrance to the performance hall. A photo ID is required for people of ages 16 to 74.

  • All spectators aged 10 and up must wear a face covering at all times: when circulating and during the performance (masks are also strongly recommended for children of ages 2 to 9).

For more information on the health and safety measures in effect at Place des Arts or to read our FAQ, please see the COVID-19 page.

Go to top